Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Cytokine profiling in the prefrontal cortex of Parkinson's Disease and Multiple System Atrophy patients

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Functional validation of ABHD12 mutations in the neurodegenerative disease PHARC

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Progression of motor axon dysfunction and ectopic Nav1.8 expression in a mouse model of Charcot-Marie-Tooth disease 1B

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Changes in total cell numbers of the basal ganglia in patients with multiple system atrophy - A stereological study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Parkinson's Disease (PD) and Multiple System Atrophy (MSA) are neurodegenerative diseases characterized neuropathologically by alpha-synuclein accumulation in brain cells. This accumulation is hypothesized to contribute to constitutive neuroinflammation, and to participate in the neurodegeneration. Cytokines, which are the main inflammatory signalling molecules, have been identified in blood and cerebrospinal fluid of PD patients, but studies investigating the human brain levels are scarce. It is documented that neurotrophins, necessary for survival of brain cells and known to interact with cytokines, are altered in the basal ganglia of PD patients. In regards to MSA, no major study has investigated brain cytokine or neurotrophin protein expression. Here, we measured protein levels of 18 cytokines (IL-2, 4-8, 10, 12, 13, 17, G-CSF, GM-CSF, IFN-γ, MCP-1, MIP-1α and 1β, TNF-α) and 5 neurotrophins (BDNF, GDNF, bFGF, PDGF-BB, VEGF) in the dorsomedial prefrontal cortex in brains of MSA and PD patients and control subjects. We found altered expression of IL-2, IL-13, and G-CSF, but no differences in neurotrophin levels. Further, in MSA patients we identified increased mRNA levels of GSK3β that is involved in neuroinflammatory pathways. Lastly, we identified increased expression of the neurodegenerative marker S100B, but not CRP, in PD and MSA patients, indicating local rather than systemic inflammation. Supporting this, in both diseases we observed increased MHC class II(+) and CD45(+) positive cells, and low numbers of infiltrating CD3(+) cells. In conclusion, we identified neuroinflammatory responses in PD and MSA which seems more widespread in the brain than neurotrophic changes.

OriginalsprogEngelsk
TidsskriftNeurobiology of Disease
Vol/bind106
Sider (fra-til)269-78
ISSN0969-9961
DOI
StatusUdgivet - 2017

ID: 51446115